Effectiveness of Combined Anticoagulation and Antithrombotic Therapy vs Antithrombotic Therapy Alone After Lower Extremity Revascularization for Peripheral Arterial Disease

NCT04994223 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Combined Anticoagulation and Antithrombotic Therapy
PAD - Peripheral Arterial Disease

Interventions

DRUG: Rivaroxaban 10 MG Oral Tablet [Xarelto]

Sponsor

Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi